Pharmacology
Download
1 / 43

Pharmacology - PowerPoint PPT Presentation


  • 44 Views
  • Uploaded on

Pharmacology. CRT 11? = 8% RRT 6?.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Pharmacology' - yuma


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Pharmacology

Pharmacology

CRT 11? = 8%

RRT 6?


  • A 30-year-old patient presents to the asthma clinic with a 2-week history of daily wheezing and nightly awakenings with shortness of breath. The patient is using Primatene Mist five times daily and fluticasone propionate (Flovent) 110 MDI occassionally at night. How should the therapist counsel the patient regarding disease management?   

  • Discontinue Primatene Mist

  • Use fluticasone propionate (Flovent) 110 MDI, 2 puffs twice daily.

  • Use salmeterol (Serevent) dry powder inhaler, 1 dose twice daily.

  • Use fluticasone propionate/salmeterol (Advair) 100/50 dry powder inhaler, one dose daily.

  • I, II, and III only

  • I, II, and IV only

  • I, III, and IV only

  • II, III, and IV only


  • A 30-year-old patient presents to the asthma clinic with a 2-week history of daily wheezing and nightly awakenings with shortness of breath. The patient is using Primatene Mist five times daily and fluticasone propionate (Flovent) 110 MDI occassionally at night. How should the therapist counsel the patient regarding disease management?   

  • Discontinue Primatene Mist

  • Use fluticasone propionate (Flovent) 110 MDI, 2 puffs twice daily.

  • Use salmeterol (Serevent) dry powder inhaler, 1 dose twice daily.

  • Use fluticasone propionate/salmeterol (Advair) 100/50 dry powder inhaler, one dose daily.

  • I, II, and III only

  • I, II, and IV only

  • I, III, and IV only

  • II, III, and IV only








Which of the following are the largest single group of drugs among aerosolized agents used for inhalation?

A. Inhaled corticosteroids

B. Adrenergic bronchodilators

C. Mucus-controlling agents

D. Anticholinergic bronchodilators


Which of the following are the largest single group of drugs among aerosolized agents used for inhalation?

A. Inhaled corticosteroids

B. Adrenergic bronchodilators

C. Mucus-controlling agents

D. Anticholinergic bronchodilators


  • Which of the following is an indication for use of an adrenergic bronchodilator?

  • Treatment of excessive, viscous mucus secretions

  • B. Antiinflammatory treatment of mild to moderate persistent asthma

  • C.Treatment of reversible airflow obstruction

  • D.Prophylactic management of asthma


  • Which of the following is an indication for use of an adrenergic bronchodilator?

  • Treatment of excessive, viscous mucus secretions

  • B. Antiinflammatory treatment of mild to moderate persistent asthma

  • C.Treatment of reversible airflow obstruction

  • D.Prophylactic management of asthma


Proventil and Ventolin are brand names for which of the following beta-adrenergic bronchodilators?

A. Albuterol

B. Isoetharine

C. Terbutaline

D. Metaproterenol


Proventil and Ventolin are brand names for which of the following beta-adrenergic bronchodilators?

A. Albuterol

B. Isoetharine

C. Terbutaline

D. Metaproterenol


An MDI of Salmeterol delivers which of the following? following beta-adrenergic bronchodilators?

A. 131 mg/puff

B. 90 mg/puff

C. 65 mg/puff

D. 25 mg/puff


An MDI of Salmeterol delivers which of the following? following beta-adrenergic bronchodilators?

A. 131 mg/puff

B. 90 mg/puff

C. 65 mg/puff

D. 25 mg/puff


Which of the following short-acting catecholamines are used for their strong alpha1 vasoconstricting effects to reduce swelling in the nose and larynx and to control bleeding during bronchoscopic biopsy?

A. Isoproterenol

B. Isoetharine

C. Dobutamine

D. Racemic epinephrine


Which of the following short-acting catecholamines are used for their strong alpha1 vasoconstricting effects to reduce swelling in the nose and larynx and to control bleeding during bronchoscopic biopsy?

A. Isoproterenol

B. Isoetharine

C. Dobutamine

D. Racemic epinephrine


Which of the following are side effects of newer, more beta2-selective bronchodilators?

A. Tremor

B. Insomnia

C. Nervousness

D. All the above


Which of the following are side effects of newer, more beta2-selective bronchodilators?

A. Tremor

B. Insomnia

C. Nervousness

D. All the above




  • Which of the following are assessment features for evaluating patient response to bronchodilator therapy?

  • Reversibility of airflow obstruction

  • II. Changes in flow rates using a peak flow meter or portable spirometry

  • III. Vital-sign changes (e.g., blood pressure, pulse rate)

  • IV. Changes in ventilation and oxygenation by arterial blood gas or pulse oximeter

  • The patient's subjective reaction to treatment

  • A. II, III, and IV

  • B. II, III, and V

  • C. I, II, III, and V

  • D. I, II, III, IV, and V


  • Which of the following are assessment features for evaluating patient response to bronchodilator therapy?

  • Reversibility of airflow obstruction

  • II. Changes in flow rates using a peak flow meter or portable spirometry

  • III. Vital-sign changes (e.g., blood pressure, pulse rate)

  • IV. Changes in ventilation and oxygenation by arterial blood gas or pulse oximeter

  • The patient's subjective reaction to treatment

  • A. II, III, and IV

  • B. II, III, and V

  • C. I, II, III, and V

  • D. I, II, III, IV, and V


What amount of Ipratropium bromide (Atrovent) is delivered by MDI?

A. 10 mg/puff

B. 15 mg/puff

C. 18 mg/puff

D. 90 mg/puff


What amount of Ipratropium bromide (Atrovent) is delivered by MDI?

A. 10 mg/puff

B. 15 mg/puff

C. 18 mg/puff

D. 90 mg/puff


What is the dosage for Ipratropium bromide (Atrovent)? by MDI?

A. 2 puffs qid

B. 2 puffs tid

C. 2 puffs bid

D. 2 puffs q12h


What is the dosage for Ipratropium bromide (Atrovent)? by MDI?

A. 2 puffs qid

B. 2 puffs tid

C. 2 puffs bid

D. 2 puffs q12h


What are some common side effects seen with Ipratropium bromide (Atrovent)?

A. Tachycardia

B. Blood pressure increase

C. Cough and dry mouth

D. Tolerance


What are some common side effects seen with Ipratropium bromide (Atrovent)?

A. Tachycardia

B. Blood pressure increase

C. Cough and dry mouth

D. Tolerance


  • Which of the following are indications for use of acetylcysteine (Mucomyst)?

  • Treatment of acetaminophen overdose

  • II. Treatment of excessive, viscous mucus secretions

  • III. Treatment of aspirin overdose

  • Treatment of purulent mucus secretions by breaking up DNA

  • A. I and II only

  • B. II and IV only

  • C. I, II, and III

  • D. I, II, III, and IV


  • Which of the following are indications for use of acetylcysteine (Mucomyst)?

  • Treatment of acetaminophen overdose

  • II. Treatment of excessive, viscous mucus secretions

  • III. Treatment of aspirin overdose

  • Treatment of purulent mucus secretions by breaking up DNA

  • A. I and II only

  • B. II and IV only

  • C. I, II, and III

  • D. I, II, III, and IV


  • Acetylcysteine (Mucomyst) lowers the viscosity of mucus by means of which of the following?

  • Breaking down DNA

  • B. Increasing the osmolarity of the mucus and pulling water into it

  • C.Changing the pH of the mucus, causing it to break down

  • D.Substituting its sulfhydryl group for disulfide bonds and breaking a portion of the bond forming the gel structure


  • Acetylcysteine (Mucomyst) lowers the viscosity of mucus by means of which of the following?

  • Breaking down DNA

  • B. Increasing the osmolarity of the mucus and pulling water into it

  • C.Changing the pH of the mucus, causing it to break down

  • D.Substituting its sulfhydryl group for disulfide bonds and breaking a portion of the bond forming the gel structure


  • Which of the following should be assessed when delivering acetylcysteine (Mucomyst)?

  • Presence of adverse effects that require treatment to be discontinued

  • II. Monitoring peak flow changes

  • III. Monitoring color, consistency, and amount of sputum

  • IV. Monitoring for presence of hydrogen sulfide (a rotten egg odor), which means that the acetylcysteine (Mucomyst) is no longer active

  • A. I and III only

  • B. I, II, and III

  • C. II, III, and IV

  • D. I, II, III, and IV


  • Which of the following should be assessed when delivering acetylcysteine (Mucomyst)?

  • Presence of adverse effects that require treatment to be discontinued

  • II. Monitoring peak flow changes

  • III. Monitoring color, consistency, and amount of sputum

  • IV. Monitoring for presence of hydrogen sulfide (a rotten egg odor), which means that the acetylcysteine (Mucomyst) is no longer active

  • A. I and III only

  • B. I, II, and III

  • C. II, III, and IV

  • D. I, II, III, and IV


  • Which of the following are acetylcysteine (Mucomyst)?true regarding glucocorticoids?

  • They work through activation of intracellular receptors.

  • II. Relief is immediate.

  • III. Daily compliance is essential to controlling inflammation in asthma.

  • IV. Taken intranasally they can control allergic and nonallergic rhinitis.

  • A. I, II, and III

  • B. I, III, and IV

  • C. II, III, and IV

  • D. I, II, III, and IV


  • Which of the following are acetylcysteine (Mucomyst)?true regarding glucocorticoids?

  • They work through activation of intracellular receptors.

  • II. Relief is immediate.

  • III. Daily compliance is essential to controlling inflammation in asthma.

  • IV. Taken intranasally they can control allergic and nonallergic rhinitis.

  • A. I, II, and III

  • B. I, III, and IV

  • C. II, III, and IV

  • D. I, II, III, and IV


  • How does cromolyn sodium work? acetylcysteine (Mucomyst)?

  • Producing antiinflammatory enzymes within cells

  • B. Inhibiting degranulation of mast cells

  • C.Preventing arachidonic acid formation from activation of mast cell membrane phospholipase A2

  • D.Leukotriene inhibition


  • How does cromolyn sodium work? acetylcysteine (Mucomyst)?

  • Producing antiinflammatory enzymes within cells

  • B. Inhibiting degranulation of mast cells

  • C.Preventing arachidonic acid formation from activation of mast cell membrane phospholipase A2

  • D.Leukotriene inhibition


  • Which of the following is acetylcysteine (Mucomyst)?true about the use of Ribavirin?

  • It is used as an antiviral agent against influenza.

  • II. It is delivered by a SPAG unit.

  • III. Adverse effects include skin rash, conjunctivitis, and eyelid erythema.

  • It can occlude endotracheal-tube and ventilator exhalation valves.

  • A. I, and II only

  • B. III and IV only

  • C. II, III, and IV

  • D. I, II, III, and IV


  • Which of the following is acetylcysteine (Mucomyst)?true about the use of Ribavirin?

  • It is used as an antiviral agent against influenza.

  • II. It is delivered by a SPAG unit.

  • III. Adverse effects include skin rash, conjunctivitis, and eyelid erythema.

  • It can occlude endotracheal-tube and ventilator exhalation valves.

  • A. I, and II only

  • B. III and IV only

  • C. II, III, and IV

  • D. I, II, III, and IV


ad